Sanofi discontinues Zika program after BARDA pulls funding
By Alicia Parker | Sep 5, 2017 | 11:28 PM GMT
Sanofi (Euronext:SAN; NYSE:SNY) said it will discontinue development of its inactivated Zika vaccine after HHS's Biomedical Advanced Research and Development Authority pulled its funding from the program
Read the full 271 word article
User Sign In
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury